Responsive image
APIs
Your position:Home > Products > APIs
API Status Specification Documentation
Rosuvastatin Ca Commercial EP EDMF, USDMF, CEP 2018
Atorvastatin Ca Commercial EP, USP EDMF, USDMF, CEP 2018
Ezetimibe Commercial In house (ICH) EDMF plan
Valsartan Commercial EP, USP EDMF, USDMF
Losartan Potassium Commercial EP, USP EDMF, CEP
Candesartan Cilexetil Commercial EP, USP EDMF plan
Olmesartan Medoxomil Commercial EP, USP EDMF
Perindopril Erbumine Commercial EP EDMF
Perindopril Arginine To be validated In house (ICH) EDMF plan
Ivabradine HCl Commercial In house (ICH) EDMF
       
Esomeprazole Mg Dihydrate Commercial EP EDMF, USDMF, CEP 2017
Esomeprazole Mg Trihydrate Commercial EP, USP EDMF, CEP 2018
Esomeprazole Na To be validated In house (ICH) EDMF plan
       
Clopidogrel Bisulfate Commercial EP, USP EDMF
Dabigatran Etexilate Mesylate To be validated  In house (ICH) EDMF plan
Ticagrelor To be validated  In house (ICH) EDMF plan
Fondaparinux Development In house (ICH) EDMF to be prepared
Rivaroxaban To be validated  In house (ICH) EDMF to be prepared
Apixaban Development In house (ICH) EDMF to be prepared
       
Venlafaxine HCl Commercial EP, USP EDMF, CEP
Duloxetine HCl Commercial EP, USP EDMF, CEP
Galantamine HBr Commercial EP, USP EDMF plan
Pregabalin Commercial In house (ICH) EDMF plan
Safinamide To be validated In house (ICH) EDMF plan
       
Vildagliptin  Commercial In house (ICH) EDMF
Alogliptin Benzoate To be validated In house (ICH) EDMF plan
Sitagliptin Phosphate To be validated In house (ICH) EDMF plan
Dapagliflozin To be validated In house (ICH) EDMF plan
       
Tenofovir Disoproxil Fumarate To be validated In house (ICH) EDMF plan
Tenofovir Alafenamide Development In house (ICH) EDMF to be prepared
Darunavir Development In house (ICH) EDMF to be prepared
Sofosbuvir Development In house (ICH) EDMF to be prepared
Velpatasvir Development In house (ICH) EDMF to be prepared
 
Erlotinib HCl Commercial In house (ICH) EDMF plan
Sorafinib Development In house (ICH) EDMF plan
Moxifloxacin HCl Commercial EP, USP EDMF
Lesinurad To be validated In house (ICH) EDMF plan
 
Fipronil Commercial In house (ICH) EDMF
Florfenicol Commercial In house (ICH) EDMF
Marbofloxacin Commercial EP EDMF
Eprinomectin To be validated In house (ICH) EDMF plan
Pradofloxacin Development In house (ICH) EDMF to be planned
Pellets List
Pellets Status Specification Documentation
Esomeprazole Mg Pellets Commercial 22.5%, 8.5%  
Orlistat Pellets Commercial 50%  
Venlafaxine HCl Pellets Commercial 46%  

 Products which are subject to patent protection are currently not offered wherein patents are in force.

Responsive image

About us

Responsive image

Products and services

Responsive image

Technology R & D

Responsive image

Quality system

Responsive image

Social responsibility

Pay attention to our
Responsive image